Search
GAZYVA 1000 MG / 40 ML, Solution à diluer pour perfusion
Details
| --- | Description |
|---|---|
| Pack | Boite contenant 1 flacon de 40 ml |
| Strength (Dosage) | 1000 MG / 40 ML |
| Laboratory | ROCHE S.A |
| Ingredients | Obinutuzumab |
| Therapeutic class | Antinéoplasique, anticorps monoclonal (anti-CD20) |
| ATC code | L01XC15 |
| PPH | $2,540.00 |
| PPV | $2,590.00 |
| Refundable | Yes |
| Refund base | $2,590.00 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | Leucémie lymphoïde chronique (LLC) Gazyvaro est indiqué en association au chlorambucil pour le traitement des patients adultes atteints de LLC non précédemment traités, et présentant des comorbidités les rendant inéligibles à un traitement à base de fludarabine à pleine dose |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications under one or more of the therapeutic classes above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem